Activation of PI3 kinase/akt signaling in chronic subdural hematoma outer membranes

Journal of Neurotrauma

Volumn 28, Issue 6, 2011, Pages 1127-1131

  Funai, Mikiko ^a   Osuka, Koji ^a   Usuda, Nobuteru ^b   Atsuzawa, Kimie ^b   Inukai, Takashi ^a   Yasuda, Muneyoshi ^a   Watanabe, Yasuo ^c   Takayasu, Masakazu ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Akt; chronic subdural hematoma; phosphatidylinositol 3 kinase; vascular endothelial growth factor

Indexed keywords

ACTIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VASCULAR ENDOTHELIAL CADHERIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; OUTER MEMBRANE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SUBDURAL HEMATOMA; WESTERN BLOTTING;

AGED; FEMALE; HEMATOMA, SUBDURAL, CHRONIC; HUMANS; MALE; MENINGES; MIDDLE AGED; PHOSPHATIDYLINOSITOL 3-KINASE; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79959716253     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2010.1498     Document Type: Article

References (28)

1. Carmeliet, P., Lampugnani, M.G., Moons, L., Breviario, F., Compernolle, V., Bono, F., Balconi, G., Spagnuolo, R., Oosthuyse, B., Dewerchin, M., Zanetti, A., Angellilo, A., Mattot, V., Nuyens, D., Lutgens, E., Clotman, F., de Ruiter, M.C., Gittenberger-de Groot, A., Poelmann, R., Lupu, F., Herbert, J.M., Collen, D., and Dejana, E. (1999). Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98, 147-157. (Pubitemid 29344903)
2. Cooke, J.P., and Losordo, D.W. (2002). Nitric oxide and angiogenesis. Circulation 105, 2133-2135. (Pubitemid 34517153)
3. Frati, A., Salvati, M., Mainiero, F., Ippoliti, F., Rocchi, G., Raco, A., Caroli, E., Cantore, G., and Delfini, R. (2004). Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. J. Neurosurg. 100, 24-32. (Pubitemid 38017811)
4. Fulton, D., Gratton, J.P., McCabe, T.J., Fontana, J., Fujio, Y., Walsh, K., Franke, T.F., Papapetropoulos, A., and Sessa, W.C. (1999). Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399, 597-601.
5. Gerber, H.P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B.A., Dixit, V., and Ferrara, N. (1998). Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3α-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 273, 30336-30343. (Pubitemid 28545503)
6. Hatanaka, K., Simons, M., and Murakami, M. (2011). Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation. Am. J. Physiol. Heart Circ. Physiol. 300, H162-H172.
7. Hong, H.J., Kim, Y.J., Yi, H.J., Ko, Y., Oh, S.J., and Kim, J.M. (2009). Role of angiogenic growth factors and inflammatory cytokines on recurrence of chronic subdural hematoma. Surg. Neurol. 71, 161-165.
8. Ito, H., Saito, K., Yamamoto, S., and Hasegawa, T. (1988). Tissuetype plasminogen activator in the chronic subdural hematoma. Surg. Neurol. 30, 175-179.
9. Katano, H., Kamiya, K., Mase, M., Tanikawa, M., and Yamada, K. (2006). Tissue plasminogen activator in chronic subdural hematomas as a predictor of recurrence. J. Neurosurg. 104, 79-84.
10. Kitamura, T., Asai, N., Enomoto, A., Maeda, K., Kato, T., Ishida, M., Jiang, P., Watanabe, T., Usukura, J., Kondo, T., Costantini, F., Murohara, T., and Takahashi, M. (2008). Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin. Nat. Cell Biol. 10, 329-337. (Pubitemid 351331020)
11. Koch, A.E., Polverini, P.J., Kunkel, S.L., Harlow, L.A., DiPietro, L.A., Elner, V.M., Elner, S.G., and Strieter, R.M. (1992). Interleukin- 8 as a macrophage-derived mediator of angiogenesis. Science 258, 1798-1801.
12. Maruo, N., Morita, I., Shirao, M., and Murota, S. (1992). IL-6 increases endothelial permeability in vitro. Endocrinology 131, 710-714.
13. Matsunaga, T., Weihrauch, D.W., Moniz, M.C., Tessmer, J., Warltier, D.C., and Chilian, W.M. (2002). Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide. Circulation 105, 2185-2191. (Pubitemid 34517163)
14. Papapetropoulos, A., Garcia-Cardena, G., Madri, J.A., and Sessa, W.C. (1997). Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 100, 3131-3139. (Pubitemid 28022851)
15. Pepper, M.S., Ferrara, N., Orci, L., and Montesano, R. (1991). Vascular endothelial growth factor (VEGF) induces plasmin- ogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun. 181, 902-906.
16. Potter, M.D., Barbero, S., and Cheresh, D.A. (2005). Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state. J. Biol. Chem. 280, 31906-31912. (Pubitemid 41291941)
17. Prandini, M.H., Dreher, I., Bouillot, S., Benkerri, S., Moll, T., and Huber, P. (2005). The human VE-cadherin promoter is subjected to organ-specific regulation and is activated in tumour angiogenesis. Oncogene 24, 2992-3001. (Pubitemid 40675530)
18. Rosenstein, J.M., Mani, N., Silverman, W.F., and Krum, J.M. (1998). Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95, 7086-7091. (Pubitemid 28278111)
19. Shono, T., Inamura, T., Morioka, T., Matsumoto, K., Suzuki, S.O., Ikezaki, K., Iwaki, T., and Fukui, M. (2001). Vascular endothelial growth factor in chronic subdural haematomas. J. Clin. Neurosci. 8, 411-415. (Pubitemid 32843692)
20. Suzuki, K., Takano, S., Nose, T., Doi, M., and Ohashi, N. (1999). Increased concentration of vascular endothelial growth factor (VEGF) in chronic subdural hematoma. J. Trauma 46, 532-533. (Pubitemid 29144362)
21. Suzuki, M., Endo, S., Inada, K., Kudo, A., Kitakami, A., Kuroda, K., and Ogawa, A. (1998). Inflammatory cytokines locally elevated in chronic subdural haematoma. Acta Neurochir. (Wien.) 140, 51-55. (Pubitemid 28052626)
22. Suzuma, K., Naruse, K., Suzuma, I., Takahara, N., Ueki, K., Aiello, L.P., and King, G.L. (2000). Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-aktdependent pathways in retinal vascular cells. J. Biol. Chem. 275, 40725-40731. (Pubitemid 32054890)
23. Tang, J., Wang, J., Kong, X., Yang, J., Guo, L., Zheng, F., Zhang, L., Huang, Y., and Wan, Y. (2009). Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway. Exp. Cell Res. 315, 3521-3531.
24. Vestweber, D. (2008). VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler. Thromb. Vasc. Biol. 28, 223-232. (Pubitemid 351161193)
25. Wallez, Y., Cand, F., Cruzalegui, F., Wernstedt, C., Souchelnytskyi, S., Vilgrain, I., and Huber, P. (2007). Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. Oncogene 26, 1067-1077.
26. Weigel, R., Schilling, L., and Schmiedek, P. (2001). Specific pattern of growth factor distribution in chronic subdural hematoma (CSH): evidence for an angiogenic disease. Acta Neurochir. (Wien.) 143, 811-818.
27. Yamashima, T., Yamamoto, S., and Friede, R.L. (1983). The role of endothelial gap junctions in the enlargement of chronic subdural hematomas. J. Neurosurg. 59, 298-303. (Pubitemid 13029211)
28. Zhang, Z.G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N., and Chopp, M. (2000). VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106, 829-838.